MaaT Pharma Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
60
- Stock Symbol
-
MAAT
- Share Price
-
$1.14
- (As of Friday Closing)
MaaT Pharma General Information
Description
Maat Pharma SA is a clinical-stage biotechnology company focused on developing microbiome-driven therapies to modulate the immune system and improve survival outcomes for patients with cancer. The company develops Microbiome Ecosystem Therapies (MET), using full-ecosystem approaches to address severe dysbiosis and unmet medical needs in oncology.
Contact Information
Website
www.maatpharma.comCorporate Office
- 70 Avenue Tony Garnier
- 69007 Lyon
- France
Corporate Office
- 70 Avenue Tony Garnier
- 69007 Lyon
- France
MaaT Pharma Timeline
MaaT Pharma Stock Performance
As of 13-Nov-2026, MaaT Pharma’s stock price is $1.14. Its current market cap is $21.4M with 18.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.14 | $1.18 | $1.01 - $10.32 | $21.4M | 18.8M | 102K | -$2.18 |
MaaT Pharma Financials Summary
As of 30-Jun-2026, MaaT Pharma has a trailing 12-month revenue of $3.7M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 40,297 | 105,163 | 99,521 | 64,030 |
| Revenue | 3,705 | 5,103 | 3,480 | 2,411 |
| EBITDA | (32,562) | (31,657) | (28,507) | (19,958) |
| Net Income | (40,020) | (35,037) | (31,277) | (21,335) |
| Total Assets | 39,036 | 52,330 | 40,063 | 47,456 |
| Total Debt | 27,152 | 18,094 | 16,605 | 15,556 |
MaaT Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MaaT Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
MaaT Pharma Comparisons
Industry
Financing
Details
MaaT Pharma Competitors (15)
One of MaaT Pharma’s 15 competitors is 4D pharma, a Corporation company based in Leeds, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 4D pharma | Corporation | Leeds, United Kingdom | ||||
| Enterome | Venture Capital-Backed | Paris, France | ||||
| PEP-Therapy | Venture Capital-Backed | Evry Cedex, France | ||||
| Seres Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Vertero Therapeutics | Venture Capital-Backed | Woburn, MA |
MaaT Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MaaT Pharma Patents
MaaT Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026099624-A1 | Pharmaceutical composition comprising iga coated bacteria for the prevention and treatment of gvhd | Pending | 06-Nov-2024 | ||
| AU-2024411225-A1 | Compositions used in combination with immune modulatory treatments for treating cancers | Pending | 29-Dec-2023 | ||
| EP-4832903-A1 | Compositions used in combination with immune modulatory treatments for treating cancers | Pending | 29-Dec-2023 | ||
| WO-2025141323-A1 | Compositions used in combination with immune modulatory treatments for treating cancers | Inactive | 29-Dec-2023 | ||
| AU-2023376170-A1 | Determination of microbiota samples to produce a target mix product and prediction of mixes | Pending | 08-Nov-2022 | G16B10/00 |
MaaT Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MaaT Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MaaT Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
MaaT Pharma FAQs
-
When was MaaT Pharma founded?
MaaT Pharma was founded in 2014.
-
Where is MaaT Pharma headquartered?
MaaT Pharma is headquartered in Lyon, France.
-
What is the size of MaaT Pharma?
MaaT Pharma has 60 total employees.
-
What industry is MaaT Pharma in?
MaaT Pharma’s primary industry is Drug Discovery.
-
Is MaaT Pharma a private or public company?
MaaT Pharma is a Public company.
-
What is MaaT Pharma’s stock symbol?
The ticker symbol for MaaT Pharma is MAAT.
-
What is the current stock price of MaaT Pharma?
As of 13-Nov-2026 the stock price of MaaT Pharma is $1.14.
-
What is the current market cap of MaaT Pharma?
The current market capitalization of MaaT Pharma is $21.4M.
-
What is MaaT Pharma’s current revenue?
The trailing twelve month revenue for MaaT Pharma is $3.7M.
-
Who are MaaT Pharma’s competitors?
4D pharma, Enterome, PEP-Therapy, Seres Therapeutics, and Vertero Therapeutics are some of the 15 competitors of MaaT Pharma.
-
What is MaaT Pharma’s annual earnings per share (EPS)?
MaaT Pharma’s EPS for 12 months was -$2.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
